What’s Delaying the Move Toward Biopharma 4.0?


We have all heard the urgent prophecy of Biopharma 4.0 – several times by now.

We have patiently listened to the grand vision of smart processes that continuously learn from data, optimize conditions and predict the future, all in a couple of seconds. A promise of a coming enterprise-wide network that promotes communication and strategic insight, while controlling manufacturing, logistics and supply chains – for shorter time-to-market at lower cost. According to research by McKinsey1, the biopharmaceutical industry could achieve a whopping 40% gain in productivity2 by this imminent paradigm shift.

So, what’s the hold up? Download our eBook to find out more…

Download now

Connect with an Expert

More eBooks

The Importance of Compliance in R&D

eBookRegardless of the industry an organization operates in, remaining compliant with ever-changing legislation is an important aspect of corporate operations.…